pyrrolidine dithiocarbamate has been researched along with Cerebral Hemorrhage in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Huang, Q; Li, F; Song, Y; Xu, Z; Zhang, Z | 2 |
Cao, J; Huang, W; Shan, W; Wang, Z; Wintermark, M; Zuo, Z | 1 |
Lee, CZ; Xue, Z; Yang, GY; Young, WL; Zhu, Y | 1 |
4 other study(ies) available for pyrrolidine dithiocarbamate and Cerebral Hemorrhage
Article | Year |
---|---|
Inhibiting nuclear factor-κB at different stages after intracerebral hemorrhage can influence the hemorrhage-induced brain injury in experimental models in vivo.
Topics: Animals; Cell Death; Cerebral Hemorrhage; Disease Models, Animal; Male; NF-kappa B; Pyrrolidines; Rats, Wistar; Thiocarbamates | 2020 |
Separate administration of ammonium pyrrolidinedithiocarbamate and phorbol myristate acetate at early and late stages decreases secondary brain injury following intracerebral haemorrhage in rats via the NF-κB pathway.
Topics: Animals; Apoptosis; Brain Injuries; Cerebral Hemorrhage; Male; NF-kappa B; Pyrrolidines; Rats; Rats, Wistar; Signal Transduction; Tetradecanoylphorbol Acetate; Thiocarbamates | 2020 |
Early administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke.
Topics: Animals; Brain Edema; Brain Infarction; Cerebral Hemorrhage; Cytokines; Drug Synergism; Fibrinolytic Agents; Intracranial Embolism; Male; Pyrrolidines; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Stroke; Thiocarbamates; Tissue Plasminogen Activator | 2018 |
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage.
Topics: Adenoviridae; Animals; Anti-Bacterial Agents; Antioxidants; Brain; Cerebral Hemorrhage; Disease Models, Animal; Humans; Intracranial Arteriovenous Malformations; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Minocycline; Pyrrolidines; Thiocarbamates; Vascular Endothelial Growth Factor A | 2007 |